Clinical Trials Browser

Phase 3 × OTHER × Resectable Non-small Cell Lung Cancer × Clear all

NCT06485557 2024-07-03

A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC

Phase 3 Not yet recruiting

Resectable Non-small Cell Lung Cancer